United States: FDA Finalizes Guidance On DHTs For Remote Data Acquisition - Exponent

Credit: Mondaq- Published on March 25, 2024
New guidance provides recommendations to ensure digital health technologies are fit-for-purpose for collecting high-quality clinical data to evaluate medical products.

You are here

Related news from verified sources

New draft guidance describes factors for determining when evidence generated from real-world data may be used to support FDA decisions on medical devices .
on March 25, 2024 • Mondaq

You might like